Home » View latest Amoxicillin Tenders from India

View latest Amoxicillin Tenders from India

TendersOnTime provides latest updates on Indian Amoxicillin Tenders from various state and central government tendering authorities. The information on Amoxicillin online tenders and turnkey projects from India is collected from various sources viz: e procurement tenders list, newspapers and tender bulletin etc.

Country: India

Amoxicillin 500Mg, Qty: 20 Nos, (BOQ Item #95)

TOT Ref No.: 103480618

Deadline: 22 Jul 2024

Country: India

Amoxicillin, Qty: 1 5G, (BOQ Item #24)

TOT Ref No.: 103604316

Deadline: 24 Jul 2024

Country: India

Supply Of Amoxicillin And Clavulinic Acid600mg Injection 1x1Vial At Bagalkot

TOT Ref No.: 103781948

Deadline: 05 Aug 2024

Country: India

Cap Amoxicillin, Qty: 350 Nos, (BOQ Item #3)

TOT Ref No.: 103922847

Deadline: 30 Jul 2024

Country: India

Cap. Amoxicillin-250, Qty: 300 Nos, (BOQ Item #4)

TOT Ref No.: 103690590

Deadline: 25 Jul 2024

Country: India

Amoxicillin Clavulunate, Qty: 2 Vial, (BOQ Item #130)

TOT Ref No.: 103755866

Deadline: 26 Jul 2024

Country: India

Supply Of Amoxicillin And Clavulinic Acid 625mg Tablets 1x10x10 At Bagalkot

TOT Ref No.: 103772447

Deadline: 05 Aug 2024

Country: India

Cap Amoxicillin 250 Mg, Qty: 30 Box, (BOQ Item #13)

TOT Ref No.: 103693485

Deadline: 25 Jul 2024

Country: India

Amoxicillin and Potassium Clavulanate Oral Suspension Ip 457Mg/5Ml,Polyethylene Glycol 3350 Powder

TOT Ref No.: 103820253

Deadline: 27 Jul 2024

Country: India

Syp Amoxicillin Plus Clavulanic Acid 457 Per 5Ml, Qty: 1 As per BoQ document, (BOQ Item #168)

TOT Ref No.: 104098671

Deadline: 02 Aug 2024

Country: {{rowDetails.Country_Name}}

TOT Ref No.: {{rowDetails.ID}}

Deadline: {{rowDetails.Bid_Deadline_1}}

Deadline: {{rowDetails.Bid_Deadline_1}}

No data Found!! Please search again

Browse Tenders

Browse Tenders from below Sections

Call Action

Get A Callback Within 24 Hours

Fill form below to get callback from Tender Experts.

Click button to send your details.